HWKN - Hawkins, Inc. Stock Analysis | Stock Taper
Logo
Hawkins, Inc.

HWKN

Hawkins, Inc. NASDAQ
$154.77 -3.32% (-5.31)

Market Cap $3.23 B
52w High $186.15
52w Low $117.98
Dividend Yield 0.58%
Frequency Quarterly
P/E 39.48
Volume 137.09K
Outstanding Shares 20.87M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2026 $265.91M $32.18M $15.46M 5.82% $0.75 $35.63M
Q3-2026 $244.08M $31.98M $14.31M 5.86% $0.69 $32.25M
Q2-2026 $280.43M $33.17M $22.6M 8.06% $1.09 $47.74M
Q1-2026 $293.27M $32.61M $29.18M 9.95% $1.41 $52.04M
Q4-2025 $245.32M $23.77M $16.33M 6.66% $0.79 $35.5M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2026 $3.91M $1B $467.69M $534.01M
Q3-2026 $8.21M $976.53M $457.62M $518.91M
Q2-2026 $10.41M $984.16M $477.2M $506.97M
Q1-2026 $14.5M $988.27M $503.7M $484.57M
Q4-2025 $5.1M $769.87M $309.57M $460.29M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2026 $15.46M $37.73M $-19.49M $-22.54M $-4.29M $18.16M
Q3-2026 $14.31M $35.56M $-18.8M $-18.97M $-2.21M $21.24M
Q2-2026 $22.6M $39.54M $-21.27M $-22.36M $-4.09M $28.74M
Q1-2026 $29.18M $31.49M $-164.54M $142.45M $9.4M $17.95M
Q4-2025 $16.33M $30.84M $-55.13M $21.08M $-3.2M $19.76M

Revenue by Products

Product Q1-2026Q2-2026Q3-2026Q4-2026
Agricultural
Agricultural
$20.00M $10.00M $10.00M $20.00M
Bulk products
Bulk products
$20.00M $20.00M $20.00M $0
Food
Food
$30.00M $20.00M $30.00M $20.00M
Nutrition
Nutrition
$40.00M $30.00M $20.00M $40.00M
Other
Other
$0 $0 $0 $0
Pharmaceutical
Pharmaceutical
$10.00M $10.00M $10.00M $10.00M

5-Year Trend Analysis

A comprehensive look at Hawkins, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Hawkins combines solid profitability, strong cash generation, and a conservative capital structure with a differentiated operating model in niche but essential markets. Its diversified segments—water treatment, health and nutrition, and industrial chemicals—provide multiple revenue streams and reduce reliance on any single end market. Operationally, the company excels in logistics, custom blending, and service, which, together with advanced water technologies and specialty ingredients, create meaningful switching costs for customers. Liquidity is sound, leverage is moderate and manageable, and retained earnings are substantial, reflecting years of consistent profitability. Overall, the business profile is that of a disciplined, service‑oriented operator with real staying power.

! Risks

Key risks center on the quality and composition of the balance sheet, the sustainability of growth, and the complexity of its operating environment. A large share of assets is tied to goodwill and other intangibles from acquisitions, which could be vulnerable to impairment if acquired businesses underperform. The modest cash balance relative to debt and ongoing investment needs increases reliance on continued strong cash generation and credit market access. Limited visibility into explicit R&D spending raises concerns about whether innovation is adequately funded internally or overly dependent on acquisitions. External risks include regulatory changes in chemicals and water treatment, environmental liabilities, cyclical end‑market demand, integration risks from continued deal‑making, and competition from both large global distributors and nimble local players.

Outlook

From the available information, Hawkins appears positioned for steady, rather than explosive, progress, underpinned by strong margins, recurring cash flows, and essential end markets like water and food-related nutrition. Opportunities in advanced water treatment—especially around emerging contaminants—and in higher‑value, clean‑label nutrition ingredients could support mix improvement and gradual growth. Continued disciplined acquisitions and capital investments may further expand capabilities and geographic reach, provided they are integrated well and deliver the expected returns. At the same time, the company’s future success will hinge on maintaining balance sheet strength, funding and executing on innovation, and navigating regulatory and competitive pressures. Overall, the outlook suggests a stable, cash‑generative business with room for incremental value creation but also a need for careful capital allocation and ongoing strategic execution.